• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者和医疗保健提供者对改善口服抗凝剂管理的患者教育的看法。

Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management.

机构信息

Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.

Clinical Pharmacology & Toxicology Research, The Research Institute of St. Joseph's Hamilton, Hamilton, Ontario, Canada.

出版信息

J Eval Clin Pract. 2022 Dec;28(6):1027-1036. doi: 10.1111/jep.13665. Epub 2022 Feb 9.

DOI:10.1111/jep.13665
PMID:35142014
Abstract

RATIONALE AND OBJECTIVES

Education of patients is thought to be key to high-quality oral anticoagulant (OAC) medication management. Theoretically, improving patients' knowledge should improve their self-management skills and adherence. The study's objective was to explore the opinions of healthcare providers and patients on the desired content and format of patient education on OACs, in addition to perceived barriers to high-quality patient education.

METHODS

We applied qualitative descriptive methods in a focus group study on OAC management. Five focus group discussions were conducted in two health regions in Southwestern Ontario from 2017 to 2018 with 19 patients, 7 caregivers and 16 healthcare providers (physicians, nurses and pharmacists). During the focus groups, participants discussed their experiences with OAC education and made suggestions about the content and format for patient education on OACs. Transcripts were analysed using conventional content analysis.

RESULTS

We identified the five themes of patient education on OAC management: content of OAC education (rationale, risk and appropriate drug administration methods), the best times for providing OAC education (time of OACs initiation along with continuing education), preferred education delivery strategies (case management targeted patient information summaries from authoritative sources such as Thrombosis Canada and video education), patient and community pharmacist engagement in OAC education, and perceived barriers to optimal patient education (patients depending too much on their healthcare providers for advice, the limited time patients spend with healthcare providers, gaps in clear communication between providers and the lack of a nationally or provincially coordinated OAC management programme).

CONCLUSION

Our findings suggest that patients, caregivers and healthcare providers support the need for education on OACs, including for patients taking DOACs. Specific important content and proper education format are needed. The optimal combination of content, format, duration, timing and sources for OAC education requires further research.

摘要

背景与目的

人们认为对患者进行教育是高质量口服抗凝药物(OAC)管理的关键。理论上,提高患者的知识水平应该能够提高其自我管理技能和依从性。本研究的目的是探讨医疗保健提供者和患者对 OAC 患者教育的内容和形式的期望,以及对高质量患者教育的障碍的看法。

方法

我们采用定性描述方法,在安大略省西南部的两个卫生区进行了一项 OAC 管理的焦点小组研究。2017 年至 2018 年,我们共进行了 5 次焦点小组讨论,参与者包括 19 名患者、7 名护理人员和 16 名医疗保健提供者(医生、护士和药剂师)。在焦点小组讨论中,参与者讨论了他们在 OAC 教育方面的经验,并对 OAC 患者教育的内容和形式提出了建议。对转录本进行了常规内容分析。

结果

我们确定了 OAC 管理患者教育的五个主题:OAC 教育的内容(原理、风险和适当的药物管理方法)、提供 OAC 教育的最佳时间(OAC 开始时以及继续教育时)、首选的教育提供策略(病例管理针对患者的信息,这些信息来自于权威来源,如加拿大血栓形成协会和视频教育)、患者和社区药剂师参与 OAC 教育,以及对最佳患者教育的障碍的看法(患者过多地依赖医疗保健提供者的建议,患者与医疗保健提供者相处的时间有限,提供者之间的沟通不明确,缺乏国家或省级协调的 OAC 管理计划)。

结论

我们的研究结果表明,患者、护理人员和医疗保健提供者支持对 OAC 进行教育,包括对接受 DOAC 治疗的患者进行教育。需要具体的重要内容和适当的教育形式。OAC 教育的内容、形式、时长、时间和来源的最佳组合需要进一步研究。

相似文献

1
Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management.患者和医疗保健提供者对改善口服抗凝剂管理的患者教育的看法。
J Eval Clin Pract. 2022 Dec;28(6):1027-1036. doi: 10.1111/jep.13665. Epub 2022 Feb 9.
2
Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers.优化口服抗凝剂管理的障碍和促进因素:患者、照护者和提供者的观点。
PLoS One. 2021 Sep 29;16(9):e0257798. doi: 10.1371/journal.pone.0257798. eCollection 2021.
3
Oral Chemotherapy: A Home Safety Educational Framework for Healthcare Providers, Patients, and Caregivers.口服化疗:面向医疗保健提供者、患者和照护者的家庭安全教育框架。
Clin J Oncol Nurs. 2020 Feb 1;24(1):22-30. doi: 10.1188/20.CJON.22-30.
4
Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.口服抗凝药物在心房颤动患者中的用药模式:韩国全国范围内基于人群的研究。
Adv Ther. 2022 Jul;39(7):3112-3130. doi: 10.1007/s12325-022-02151-z. Epub 2022 May 7.
5
Physicians' Perceptions of Their Patients' Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria.保加利亚医生对患者长期口服抗凝治疗的态度和知识的看法。
Medicina (Kaunas). 2019 Jun 26;55(7):313. doi: 10.3390/medicina55070313.
6
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
7
Barriers and facilitators to optimal oral anticoagulant management: a scoping review.优化口服抗凝剂管理的障碍与促进因素:一项范围综述
J Thromb Thrombolysis. 2020 Oct;50(3):697-714. doi: 10.1007/s11239-020-02056-0.
8
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study.非维生素 K 拮抗剂口服抗凝剂取代华法林后心房颤动患者的初级保健管理变化:一项挪威基于人群的研究。
BMC Prim Care. 2022 Aug 25;23(1):214. doi: 10.1186/s12875-022-01824-6.
9
Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.评估中国缺血性卒中和心房颤动患者基于指南的口服抗凝药物处方的趋势。
JAMA Netw Open. 2021 Jul 1;4(7):e2118816. doi: 10.1001/jamanetworkopen.2021.18816.
10
Contemporary oral anticoagulant therapy of patients with atrial fibrillation in China: Status, obstacles, and strategies for improvement.当代中国心房颤动患者的口服抗凝治疗:现状、障碍和改善策略。
Biosci Trends. 2022 Nov 20;16(5):317-329. doi: 10.5582/bst.2022.01278. Epub 2022 Oct 30.

引用本文的文献

1
Assessment of Knowledge and Medication Adherence Among Patients Prescribed with Oral Anticoagulants in Atrial Fibrillation at a Tertiary Care Centre: A Cross Sectional Study.三级医疗中心心房颤动患者口服抗凝剂知识与用药依从性评估:一项横断面研究
J Blood Med. 2024 Dec 20;15:533-547. doi: 10.2147/JBM.S493313. eCollection 2024.
2
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban: A Cross-Sectional Survey of Atrial Fibrillation Patients.不坚持使用直接口服抗凝药阿哌沙班的原因:一项心房颤动患者的横断面调查
JACC Adv. 2023 Jan 27;2(1):100175. doi: 10.1016/j.jacadv.2022.100175. eCollection 2023 Jan.
3
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial.
出院时口服抗凝药物管理的协调(COACHeD):试点随机对照试验。
BMJ Open. 2024 May 1;14(5):e079353. doi: 10.1136/bmjopen-2023-079353.
4
Postpartum and interpregnancy care of women with a history of hypertensive disorders of pregnancy.有妊娠高血压病史的女性的产后和妊娠间隔期护理。
Hypertens Res. 2024 Jun;47(6):1457-1469. doi: 10.1038/s41440-024-01641-7. Epub 2024 Mar 11.
5
Knowledge, attitude and practice toward oral anticoagulants among patients with atrial fibrillation.心房颤动患者对抗凝剂的认知、态度及实践
Front Cardiovasc Med. 2023 Dec 15;10:1301442. doi: 10.3389/fcvm.2023.1301442. eCollection 2023.